Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies

Michele Cea, Debora Soncini, Marco Gobbi, Roberto M. Lemoli, Antonia Cagnetta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalExpert Review of Anticancer Therapy
Publication statusAccepted/In press - Jul 23 2016


  • BTK inhibitor
  • lymphomas
  • NAD+ depletion
  • Novel therapies
  • tumor metabolism

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this